Large-scale testing (Phase 3)Ended earlyNCT02641639
What this trial is testing
FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer
Who this might be right for
Platinum Resistant Ovarian Cancer
Mateon Therapeutics 70